Abstract
With the advances of genetics in cardiovascular disease, increasingly more information on genetics and its associated phenotypes is becoming available, often online. The physician dealing with cardiovascular genetic disorders has to be able to interpret genetic test results and implement this in patient care including genetic counseling, risk assessment and, possibly personalized, treatment.
To be able to navigate through the online resources available, we summarized some databases and online tools on the interpretation of genetic variants; i.e. databases that assess the pathogenicity using in silico computional models, databases with data on the presence of variants in control populations and disease or gene specific databases that summarize variants and its associated phenotypes.
In addition to these variant-interpretation databases, databases to aid the clinician in making a diagnosis, predicting a positive genetic test or risk assessment are summarized. Finally websites that facilitate data-sharing are mentioned.
Even though these tools are very useful, one has to be aware that online data are not always up-to-date and the interpretation of data that are used, especially in patient care, always need a critical review. This should be considered a multidisciplinary teams effort that involve amongst others cardiologists, clinical and molecular geneticists, and genetic counselors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Green RC, Berg JS, Grody WW, et al. American college of medical genetics and genomics ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–74.
Mogensen J, van Tintelen JP, Fokstuen S, et al. The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics. Eur Heart J. 2015;36:1367–70. https://doi.org/10.1093/eurheartj/ehv122.
Choi Y, Sims GE, Murphy S, et al. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7:e46688.
Richards S, Aziz N, Bale S, et al. ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.
Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nature Methods. 2010;7:575–576. https://doi.org/10.1038/nmeth0810-575.
Kircher M, Witten DM, Jain P, et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5. https://doi.org/10.1038/ng.2892.
Monkol Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91. https://doi.org/10.1038/nature19057.
Walsh R, Thomson KL, Ware JS, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016;19(2):192–203. https://doi.org/10.1038/gim.2016.90. [Epub ahead of print]
Genome of the Netherlands Consortium. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet. 2014;46:818–25. https://doi.org/10.1038/ng.3021.
Christensen AH, Kamstrup PR, Gandjbakhch E, et al. Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population. Eur J Hum Genet. 2016;24:732–8. https://doi.org/10.1038/ejhg.2015.171.
De Bortoli M, Beffagna G, Bauce B, et al. The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy. Eur J Hum Genet. 2010;18:776–82. https://doi.org/10.1038/ejhg.2010.19.
Groth KA, Gaustadnes M, Thorsen K, et al. Difficulties in diagnosing Marfan syndrome using current FBN1 databases. Genet Med. 2016;18:98–102. https://doi.org/10.1038/gim.2015.32.
Lazzarini E, Jongbloed JD, Pilichou K, et al. The ARVD/C genetic variants database: 2014 update. Hum Mutat. 2015;36:403–10.
van der Zwaag PA, Jongbloed JD, van den Berg MP, et al. A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat. 2009;30:1278–83.
Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533–41. https://doi.org/10.1161/CIRCULATIONAHA.108.840827.
Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476–85. https://doi.org/10.1136/jmg.2009.072785.
Bos JM, Will ML, Gersh BJ, et al. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc. 2014;89:727–37. https://doi.org/10.1016/j.mayocp.2014.01.025.
Gruner C, Ivanov J, Care M, et al. Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2013;6:19–26. https://doi.org/10.1161/CIRCGENETICS.112.963363.
Olde Nordkamp LR, Postema PG, et al. Implantable cardioverter-defibrillator harm in young patients withinherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13:443–54. https://doi.org/10.1016/j.hrthm.2015.09.010.
Olde Nordkamp LR, Wilde AA, Tijssen JG, et al. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Circ Arrhythm Electrophysiol. 2013;6:91–100. https://doi.org/10.1161/CIRCEP.112.975268.
O'Mahony C, Jichi F, Pavlou M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014;35:2010–20. https://doi.org/10.1093/eurheartj/eht439.
van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59:493–500. https://doi.org/10.1016/j.jacc.2011.08.078.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
van Tintelen, J.P., van der Zwaag, P.A. (2018). Inherited Cardiovascular Conditions: Phenotype-Genotype Data Mining and Sharing, and Databases. In: Kumar, D., Elliott, P. (eds) Cardiovascular Genetics and Genomics. Springer, Cham. https://doi.org/10.1007/978-3-319-66114-8_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-66114-8_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66112-4
Online ISBN: 978-3-319-66114-8
eBook Packages: MedicineMedicine (R0)